Sermorelin mastery course
Unit 5 of 11
Pediatric growth hormone deficiency
The one setting where sermorelin has real controlled data is pediatric growth hormone deficiency. This was the indicati…
The approved past: sermorelin’s strongest, and oldest, direct evidence
The one setting where sermorelin has real controlled data is pediatric growth hormone deficiency. This was the indication it was approved for, and the pivotal trial showed children growing faster on nightly sermorelin.
This unit covers what pediatric GHD is, the Geref trial that anchors the evidence, the approval and its 2008 withdrawal, and why recombinant GH ultimately took over the indication.